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OBJECTIVES Our goal was to describe the functional status of cardiogenic shock survivors, identify the
correlates of cardiogenic shock, and compare global quality of life and functional status of
patients randomly assigned to treatment with emergency revascularization (ERV) versus
initial medical stabilization (IMS).
BACKGROUND Historically, the hospital survival rate of patients with cardiogenic shock complicating acute
myocardial infarction (MI) has been very low. Shock survivors are salvaged from a critically
ill state, and their later functional status is not well documented. The SHould we emergently
revascularize Occluded Coronaries for cardiogenic shocK (SHOCK) trial showed signifi-
cantly improved one-year survival after ERV compared with IMS.
METHODS The SHOCK trial survivors completed interviews at 2 weeks after discharge and at 6 and 12
months after MI. Functional status assessment included the Multidimensional Index of Life
Quality and New York Heart Association (NYHA) congestive heart failure functional class.
RESULTS Eighty-seven percent of one-year survivors of the SHOCK trial were in NYHA functional
class I or II. Between two weeks after discharge and one year after MI, improvement was
similar in the two treatment groups (18% overall), but fewer patients remained stable (44% vs.
71%), and more patients worsened or died (34% vs. 15%) in the IMS group compared with those
assigned to ERV. Assignment to ERV was the only independent predictor of outcome at one year.
CONCLUSIONS Although one-year mortality after ERV is still high (54%), most survivors have good
functional status. The ERV patients have a lower rate of deterioration than IMS patients.
The level of recovery for shock patients undergoing ERV is similar to that of historical
controls not in cardiogenic shock undergoing elective revascularization. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.0612005;46:266–73) © 2005 by the American College of Cardiology Foundation
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Nince the mid-1990s, the in-hospital mortality rate for
atients with acute myocardial infarction (MI) complicated
y cardiogenic shock has ranged from 60% to 70% (1,2).
See page 274
he SHould we emergently revascularize Occluded Coro-
aries for cardiogenic shocK (SHOCK) trial showed that
dditional lives can be saved with emergency revasculariza-
ion, reducing the mortality rate to 51% at six months (3).
owever, because of the extensive myocardial damage
aused by the disease process before revascularization, shock
From the *New England Research Institutes, Watertown, Massachusetts; †New
ork University School of Medicine, New York, New York; ‡Massachusetts General
ospital, Boston, Massachusetts; §Division of Cardiology, Albert Einstein College of
edicine, Bronx, New York; Department of Cardiology, Auckland City Hospital,
uckland, New Zealand; ¶Toronto General Hospital, Toronto, Ontario, Canada;
St. Luke’s/Roosevelt Hospital Center, New York, New York; and **Wake Forest
niversity Health Sciences, Winston-Salem, North Carolina. This work was completed
ith support from research grants R01 HL49970 and R01 HL50020 from the
ational Heart, Lung, and Blood Institute of the National Institutes of Health,
ethesda, Maryland.t
Manuscript received November 4, 2004; revised manuscript received January 7,
005, accepted January 11, 2005.urvivors may have severely limited long-term functional
tatus. Salvage of critically ill patients by revascularization
mproves survival, but it is not known whether survivors are
estricted in their activities by symptoms of severe heart
ailure and whether they have a poor quality of life.
We report the effect of a strategy of emergency revascu-
arization (ERV) for cardiogenic shock complicating acute
I on functional status and quality of life of patients
nrolled in the SHOCK trial. The findings of patient
nterviews from 2 weeks after discharge and 6 and 12
onths after MI are summarized. The association between
unctional status and long-term survival is explored, and the
atterns of recovery for shock patients undergoing ERV and
historical sample of patients not in cardiogenic shock
ndergoing elective revascularization are compared.
ETHODS
articipants. Patients were enrolled from April 1993 to
ovember 1998 at 30 international sites via computerizedelephone randomization. All patients (or their surrogate)
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July 19, 2005:266–73 Functional Status After Emergency Revascularizationigned an informed consent form, approved by the institu-
ional review board or ethics committee of the clinic site.
rial design. The SHOCK trial was a randomized, un-
linded, multi-center trial comparing the effects of ERV
nd initial medical stabilization (IMS) strategies with re-
pect to 30-day, 6-month, and 1-year survival (4). Patients
ith acute MI who developed cardiogenic shock caused by
redominant left ventricular failure within 36 hours of MI
nset were eligible for the trial if the electrocardiogram
howed ST-segment elevations or Q waves, posterior in-
arction, or new or presumably new left bundle block.
andomization had to be accomplished within 12 h of
hock diagnosis. Strict clinical and hemodynamic criteria for
hock were required, including sustained hypotension (systolic
lood pressure 90 mm Hg or need for vasopressors), tissue
ypoperfusion, pulmonary capillary wedge pressure 15 mm
g, and cardiac index 2.2 l/min/m2. Exclusion criteria
ncluded other etiologies of cardiogenic shock, including me-
hanical complications, prior cardiomyopathy or valvular heart
isease, severe systemic illness, and inability to perform cardiac
atheterization or known unsuitable coronary anatomy.
nterventions. Patients randomized to a strategy of at-
empted ERV were required to undergo either angioplasty
r coronary artery bypass graft surgery, if feasible, within six
ours of randomization. Patients randomized to a strategy
Abbreviations and Acronyms
ERV  emergency revascularization
IMS  initial medical stabilization
MI  myocardial infarction
MILQ  Multidimensional Index of Life Quality
NYHA  New York Heart Association
SHOCK  SHould we emergently revascularize
Occluded Coronaries for cardiogenic shocKigure 1. The SHOCK trial patient flow: follow-up interviews and one-year ou
tatus unknown for one participant assigned to the initial medical stabilizationf IMS could be considered for angioplasty or coronary
rtery bypass graft surgery 54 h after randomization. Intra-
ortic balloon counterpulsation was recommended for all
atients (used in 86%), and thrombolytic therapy was
trongly recommended for the IMS group, unless an abso-
ute contraindication was present.
utcomes. The primary study end point of the SHOCK
rial was 30-day mortality. Secondary end points of the trial
resented in this article include six-month and one-year
urvival, functional status, and quality of life.
ample size. The SHOCK trial enrolled 302 patients. One
undred fifty-two patients were randomly assigned to ERV,
nd 150 were assigned to IMS. Figure 1 summarizes the
atient sample analyzed for this report. There were 158
n-hospital deaths and 2 patients who survived after heart
ransplantation during the shock hospitalization. The sample
or this analysis is composed of the remaining 142 patients (77
ssigned to ERV and 65 assigned to IMS) who were eligible
or follow-up interviews. Sixteen of the hospital survivors had
o interviews completed after discharge (11%). One patient in
he IMS group was lost to follow-up at one year.
ata collection after hospital discharge. For patients
ischarged alive, up to three follow-up interviews to collect
nformation on quality of life and physical function were
onducted: 1) 2 weeks after discharge (window 10 days to 2
onths, median 3 weeks), 2) 6 months after index MI
window 3 to 9 months, median 6.6 months), and 3) 1 year
fter index MI (window 9 to 18 months, median 12.6
onths). Global quality of life was measured using three
ikert scale questions, including the Andrews Ladder of
ife (5) (Appendix). Functional status according to the New
ork Heart Association (NYHA) congestive heart failure
unctional classification system was measured using four
tandardized questions. For 35 patients who were random-
zed early in the study, NYHA functional classification wastcome. Bolded boxes indicate cohorts included in this report. *One-year
group.
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Functional Status After Emergency Revascularization July 19, 2005:266–73ssessed in at least one interview using questions from the
odified Sickness Impact Profile. Functional status was also
easured using the Multidimensional Index of Life Quality
MILQ), a validated instrument designed specifically to
ssess quality of life in patients with cardiovascular disease
6). Each MILQ domain score was based on four questions
nswered using a seven-point Likert scale (Appendix). The
ILQ and the life satisfaction questions are valid only if
nswered by the patient, and therefore were not adminis-
ered to proxy respondents (40, or 14% of the 287 interviews
btained within window, with no significant difference
etween treatment groups).
There were 16 patients eligible for follow-up (11%) who
id not complete any post-discharge interviews. Five of the
6 came from one clinic site, and 6 died in the year after MI.
he non-interviewed cohort was similar to the group of 126
atients who had at least one follow-up interview with
espect to treatment group assignment (50% vs. 55% in the
RV group, p  0.79). Seventy percent (92 patients) of
ix-month survivors and 75% (89 patients) of one-year
urvivors were included in the six-month and one-year
nalyses, respectively. Seven of the interviews classified as
navailable were actually completed, but were outside of the
ime window specified for analysis. Inclusion of the out-of-
indow interviews (2 to 4 months after discharge; and 9 to
0 months rather than 6 months post-MI) did not signifi-
antly alter the study findings.
tatistical methods. Survival end points were calculated
rom the time of randomization. Per protocol, follow-up
ata were not collected for two survivors who underwent
eart transplantation during the shock hospitalization. The
Table 1. Characteristics of SHOCK Trial Hos
Interview, by Treatment Group Assignment
Characteristic
Initi
Sta
(
Age (yrs) 64
Male
MI onset to shock (median h)
Prior MI
Diabetes
Congestive heart failure
Prior hypertension
Anterior MI
Median highest creatine kinase (IU)
Systolic blood pressure (mm Hg)* 8
Diastolic blood pressure (mm Hg)* 5
Cardiac index (l/min/m2)* 1.7
Left ventricular ejection fraction (%)† 34
Thrombolytic therapy
Revascularization attempt‡
Length of hospital stay (median days)
*Measurement closest to shock diagnosis, often obtained whi
for 26 IMS and 34 ERV patients. ‡Revascularization during t
underwent delayed revascularization, this was performed in 40.4%
ERV  emergency revascularization; IMS  initial medical stailcoxon rank sum test was used to compare the distribu-
ion of the global quality of life questions by treatment
roup at a given time point and by one-year vital status. The
antel-Haenszel test for linear trend and the Fisher Exact
est were used to compare the distributions of NYHA
unctional class (I to IV) by treatment group and by survival
tatus at one year within treatment group. Logistic regres-
ion modeling (7) was used to identify independent corre-
ates of one-year outcome (NYHA functional class I/II vs.
II/IV/dead). The Wilcoxon rank sum test was used to
ompare physical function domain scores by treatment
roup. A model-based estimate of NYHA congestive heart
ailure functional classification was used for 35 patients for
hom standardized NYHA functional classification re-
ponses were not available. The model was developed from
atients with measured NYHA functional class, using
ogistic regression with questions from the modified Sick-
ess Impact Profile as predictors. All statistical analyses
ere conducted with SAS software (Statistical Analysis
ystem for Windows version 8.2, 2001, SAS Institute, Inc.,
ary, North Carolina).
ESULTS
atient sample. At randomization, the mean age of the
26 patients with at least one post-discharge interview was
3.4  11.1 years. The two treatment groups were similar
ith respect to age and other baseline characteristics (Table
): 69% were male, 28% had prior MI, 30% had diabetes
ellitus, and 42% had a history of hypertension. Ninety-
hree percent of the ERV and 40% of the IMS patients in
Survivors With at Least One Follow-Up
Treatment Assignment
edical
tion
7)
Emergency
Revascularization
(n  69) p Value
12.6 62.6  9.7 0.373
68.1% 0.848
5.0 0.260
30.4% 0.550
33.0% 0.332
4.4% 0.700
42.7% 0.856
54.6% 0.856
3,335 0.724
16 90  21 0.711
15 54  14 0.543
0.46 1.92  0.72 0.394
11.4 33.6  11.4 0.835
52.2% 0.010
92.8% 0.001
15.0 0.523
upport measures. †Obtained by echocardiography; available
pitalization for shock. Although only 25% of the IMS grouppital
al M
biliza
n  5
.3 
70.2%
6.4
24.6%
25.0%
7.1%
40.4%
51.8%
3,716
8 
5 
8 
.4 
75.4%
40.4%
16.0
le on s
he hosof hospital survivors.
bilization; MI  myocardial infarction.
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July 19, 2005:266–73 Functional Status After Emergency Revascularizationhe interview cohort underwent a revascularization attempt
uring the shock hospitalization. The post-discharge revas-
ularization rates at one year were similar (4%) in the ERV
nd IMS groups: three ERV patients underwent percutaneous
oronary intervention or coronary artery bypass graft after
ischarge, and two IMS patients underwent coronary artery
ypass graft (one of whom underwent percutaneous coronary
ntervention during the hospitalization for shock). Of the 27
atients with at least one proxy interview, 3 were noted to have
ad a stroke. At one year, the 9 proxy respondents (9% of 98
nterviews at one year) indicated 1 patient unwilling to be
nterviewed, 4 unable to answer questions or mostly bedridden,
nd 4 in the hospital (1 non-cardiac, 3 cardiac).
YHA functional classification. At two weeks after dis-
harge, the distributions of NYHA functional class by
reatment assignment were similar (p 0.131): 62.5% of 48
atients assigned to IMS and 75.9% of 58 patients assigned
o ERV were class I or II (Table 2). Figure 2 shows that the
roportion of patients in NYHA functional class I or II
emained fairly constant over time. However, the propor-
ion of NYHA functional class III and IV patients de-
reased over time as deaths occurred, with proportionately
ore deaths in the IMS group (treatment group comparison
f class I or II vs. III or IV vs. deceased: p  0.035 at six
onths post-MI and p  0.014 at one year post-MI). The
nding of more one-year survivors in the ERV group
ompared with the IMS group without a proportionate
ncrease in the number of NYHA functional class III or IV
atients who underwent ERV indicates a marked improve-
ent in survival without disability. Table 3 shows the
ransition rates from functional class at two weeks after
ischarge to one-year post-MI. Similar proportions of
atients improved in both treatment groups (22% in IMS
nd 15% in ERV group), but fewer patients remained stable
44% vs. 71%) and more patients worsened (34% vs. 15%) in
he IMS group. Among those alive at each follow-up,
owever, the distributions of NYHA functional class for the
wo treatment groups were similar (Table 2).
he MILQ. Among one-year survivors, the MILQ phys-
cal function domain scores of the two treatment groups
Table 2. NYHA Congestive Heart Failure Fun
Assignment, All Available Data
Treatment
Assignment (n)
NYH
I
2 weeks after discharge
IMS (48) 37.5 2
ERV (58) 46.6 2
6 months post-MI
IMS (37) 54.1 1
ERV (55) 54.6 1
1 yr post-MI
IMS (35) 57.1 2
ERV (54) 57.4 2
*Mantel-Haenszel test for linear trend.
ERV  emergency revascularization; NYHA  New YoTable 4) were similar at one year (19.1 vs. 19.3). Table 4
A
clso shows mean MILQ scores separately for angioplasty and
oronary artery bypass graft surgery patients in the ERV group.
n increase in physical functioning over one year was observed
or coronary artery bypass graft patients. Physical function
cores for angioplasty patients were highest at six months.
At two weeks after discharge, patients assigned to the
RV group had better quality of life scores in three of the
ine MILQ domains: mental health (21.7  4.8 vs. 19.3 
.8, p  0.048), physical health, measuring energy and pain
evels (19.6  5.1 vs. 15.9  5.8, p  0.003), and financial
tability (20.2  6.9 vs. 16.3  7.4, p  0.019). The mean
ILQ physical function domain score (measuring ability to
erform physical tasks) of patients assigned to the ERV
roup was similar to that of their IMS counterparts at two
eeks (16.4 5.6 vs. 14.4 7.4, p 0. 198). At later time
oints, the MILQ domain scores of the ERV and IMS
urviving cohorts were similar.
verall life satisfaction. The distributions of responses
egarding global quality of life from one-year survivors were
igure 2. Outcome of 126 SHOCK trial hospital survivors with at least
ne interview, 69 assigned to the emergency revascularization (ERV) group
nd 57 assigned to the initial medical stabilization (IMS) group. There
ere significant differences between treatment groups at six months (p 
.035) and one year (p  0.014) White bars  New York Heart
al Class by SHOCK Trial Treatment
nctional Class (%)
p Value*III IV
0.131
12.5 25.0
10.3 13.8
0.800
8.1 21.6
12.7 16.4
0.676
2.9 17.1
1.9 13.0
art Association; IMS  initial medical stabilization.ction
A Fu
II
5.0
9.3
6.2
6.4
2.9
7.8ssociation (NYHA) functional class I/II; ruled bars NYHA functional
lass III/IV; black bars  deceased. MI  myocardial infarction.
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Functional Status After Emergency Revascularization July 19, 2005:266–73imilar for the two treatment assignments at each time
oint. The Andrews Ladder of Life (1 worst possible life,
0  best possible life) had median scores of 5.0 for IMS
atients (n  31) and 7.0 for ERV patients (n  49) at two
eeks after discharge (p  0.256). The median score for
oth groups was 7.0 at both six months and one year
ost-MI. The summary health question (“In general, how
ould you say your health is right now?”), which ranged
rom 1 denoting excellent health to 5 denoting poor health,
ad two-week median scores of 3.5 and 3.0 (good health)
or IMS and ERV patients, respectively. The median score
ontinued to be 3.0 for both groups in later interviews. The
verall life satisfaction question ranged from 1 denoting
omplete dissatisfaction to 7 denoting complete satisfaction.
edian scores for this question were 5.0 and 6.0 for IMS
nd ERV patients, respectively, at two weeks after discharge
p  0.142) and six months post-MI, and 5.0 for both
roups at one year.
rediction of long-term outcome. It was of interest to
dentify factors from the time of hospitalization to discharge
hat were correlated with a poor outcome (defined as
YHA functional class III or IV or death) at one year
ost-MI. Table 5 compares 74 patients in NYHA func-
ional class I or II at one year post-MI with 37 patients with
oor outcome at one year post-MI. The only statistically
Table 3. NYHA Congestive Heart Failure Fun
Versus Outcome at One Year After MI*
NYHA Class at Two
Weeks After Discharge
Function
I/II
Initial medical stabilization
I/II 65.2% (15)
No change
III/IV 50.0% (9)
Improved
Emergency revascularization
I/II 86.5% (32)
No change
III/IV 63.6% (7)
Improved
*The number of patients in each cell is shown in parentheses
with no one-year interview are excluded.
MI  myocardial infarction; NYHA  New York Hear
Table 4. MILQ Physical Function Domain Sc
Modality and Time*
Cohort
Maxim
n
Initial medical stabilization 23
Emergency revascularization 41
Angioplasty 24
Bypass surgery‡ 17
Avis et al. (5), scheduled angioplasty§ 22
Avis et al. (5), scheduled bypass surgery§ 66
*Mean  standard deviation scores are based on all available d
et al. (6) cohort; not all patients had acute MI. ‡Includes t
personal communication, April 2001. Unpublished MILQ data.
MI  myocardial infarction; MILQ  multidimensional Indexignificant factors were assignment to the emergency revas-
ularization group (62.2% of NYHA functional class I or II
s. 40.5% of class III or IV or deceased patients, p  0.043)
nd NYHA functional class at two weeks after discharge (p
0.045; 22 patients with missing two-week data). Other
actors with a suggestive association were a history of
ypertension (p  0.067), chest pain at presentation (p 
.084), index MI with new left bundle branch block (p 
.077), and systolic blood pressure at the time of shock (p
.075). A multivariate logistic regression model (N  106)
xamining these factors showed that assignment to emer-
ency revascularization (odds ratio [OR] 0.31, 95% confi-
ence interval 0.13 to 0.76, p  0.011), systolic blood
ressure from the time of shock onset (OR per 10-mm Hg
ncrease 0.78, 95% confidence interval 0.60 to 1.02, p 
.066) and chest pain at presentation (OR 3.96, 95%
onfidence interval 0.77 to 20.30, p  0.099) were the only
ndependent predictors at the 0.10 significance level of
atient status one year after MI.
ISCUSSION
atients who initially survive cardiogenic shock, typically a
ethal complication of an acute MI, have improved long-
erm survival with good functional status. A strategy of early
al Class at Two Weeks After Discharge
lass and Vital Status at One Year Post-MI
III/IV Deceased Total
8.7% (2) 26.1% (6) 100% (23)
eterioration Deterioration
16.7% (3) 33.3% (6) 100% (18)
change Deterioration
8.1% (3) 5.4% (2) 100% (37)
eterioration Deterioration
18.2% (2) 18.2% (2) 100% (11)
change Deterioration
y-six patients without two-week interviews and 17 survivors
ciation.
of One-Year Survivors by Treatment
Two Weeks
After Discharge†
Six Months
Post-MI
One Year
Post-MI
15.9  7.9 17.3  5.7 19.3  4.4
17.1  5.2 19.9  6.4 19.1  6.2
16.8  5.3 21.4  6.6 17.7  6.3
18.1  5.2 18.3  6.2 20.9  6.1
20.3 21.6 not available
17.3 22.2 not available
each time point. †Six weeks after the procedure for the Avis
atients with bypass surgery after angioplasty. §Smith KW,ction
al C
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July 19, 2005:266–73 Functional Status After Emergency Revascularizationevascularization is an independent strong predictor of
urvival with good functional status at one year.
The SHOCK trial showed that a strategy of early
evascularization confers a one-year survival advantage over
nitial medical stabilization with delayed revascularization
or patients with cardiogenic shock complicating acute MI
3). The results of this trial confirmed previous non-
andomized study findings suggesting improved survival in
ardiogenic shock with early revascularization. The func-
ional capacity and life satisfaction of patients with estab-
ished severe heart failure is poor (8) but is not known for
urvivors of cardiogenic shock. Previous studies lacked the
ecessary study design to assess long-term functional status
nd life satisfaction. They were non-randomized, retrospec-
ive, and confounded by selection bias with referral of less ill
atients for revascularization. Small series of cardiogenic
hock patients supported the use of ventricular assist devices
sing surrogates such as “return to work” (9). The SHOCK
rial included functional status and quality of life as second-
Table 5. SHOCK Trial Patient Characteristics
Year Post-MI
Characteristic
Number of patients
Age (yrs)
Age 75 yrs
Male gender
Median time from myocardial infarction to shock (h
White, non-Hispanic
Chest pain at presentation
History of myocardial infarction
History of hypertension
Diabetes mellitus
Peripheral vascular disease
History of congestive heart failure
Anterior myocardial infarction
New left bundle branch block
Median highest creatine kinase (IU)
Number of diseased vessels at shock diagnosis
0/1
2
3
Left main disease at shock diagnosis
Lowest systolic blood pressure before randomization
Systolic blood pressure (mm Hg)*
Diastolic blood pressure (mm Hg)*
Heart rate (beats/min)
Cardiac index (l/min/m2)*
Pulmonary capillary wedge pressure (mm Hg)*
Pre-discharge left ventricular ejection fraction (%)†
Revascularization attempt
NYHA functional class III or IV at two weeks post-
Assigned to emergency revascularization group
Functional status at one year post-MI is unknown for 31 pat
onset. †n  41 in class I/II and n  19 in class III/IV/dead
26 in class III/IV/dead for NYHA class at two weeks after
Abbreviations as in Table 3.ry end points to be evaluated in all hospital survivors. sEarly revascularization in cardiogenic shock is thought to
elieve ischemia and thereby interrupt the cycle of events
hat results in further myocyte necrosis and depressed
yocardial contractility. Furthermore, early revasculariza-
ion may influence the remodeling process that follows MI.
owever, shock classically occurs in patients with severe left
entricular damage (10). The substantial survival advantage
f early revascularization could theoretically result in the
alvage of critically ill patients with severe left ventricular
ysfunction and poor functional status. Reassuringly, this
as not the case. Eighty-three percent of one-year survivors
85% in the ERV group and 80% in the IMS group)
eported minimal functional limitation (NYHA functional
lass I or II). This good outcome may be in part attributable
o the fact that these patients have not experienced the years
f physical deconditioning that are characteristic of those
ith chronic heart failure, and shows the dissociation between
ystolic ventricular performance and functional status.
The SHOCK trial patient physical function domain
111) by NYHA Functional Class at One
NYHA Functional Class
at One Year
p ValueI/II III/IV/Dead
74 37
63.5  11.0 65.3  11.6 0.425
17.6% 16.2% 1.00
71.6% 70.3% 1.00
5.5 7.0 0.556
75.7% 67.6% 0.374
81.1% 94.6% 0.084
23.0% 37.8% 0.119
36.5% 55.6% 0.067
31.5% 35.1% 0.830
8.0% 19.2% 0.260
2.7% 8.3% 0.328
54.2% 55.6% 1.00
5.4% 16.7% 0.077
3,432 3,100 0.854
0.067
19.2% 9.4%
31.5% 21.9%
49.3% 68.8%
16.4% 18.2% 0.788
70  11 68  10 0.525
92  20 85  14 0.075
56  15 52  13 0.253
99  24 99  22 0.952
1.8  0.7 1.8  0.4 1.00
23.1  6.3 24.2  6.7 0.468
35.0  12.7 31.4  12.9 0.262
74.3% 59.5% 0.129
arge‡ 25.4% 50.0% 0.045
62.2% 40.5% 0.043
live at one year. *Measured while on support close to shock
e-discharge ejection fraction. ‡n  63 in class I/II and n 
ge.(n 
)
*
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cale studied a cohort of 22 patients undergoing scheduled
ercutaneous revascularization and 66 undergoing coronary
rtery bypass surgery (5). This cohort was 61  10 years old
nd 81% male. Over one-half (53%) had a previous MI,
3% had diabetes, and 46% had hypertension. The level and
iming of recovery of SHOCK trial patients assigned to
mergency angioplasty was similar to that of the historical
ohort with scheduled angioplasty (Table 4). The SHOCK
rial emergency bypass surgery patients also had recovery of
unction similar to that of patients with scheduled proce-
ures, but with a six-month delay; that is, the one-year
cores of SHOCK trial patients are similar to the six-month
cores of the scheduled bypass surgery patients.
Patients assigned to emergency revascularization who
ere in NYHA functional class I or II at two weeks after
ischarge remained remarkably stable over one year. In
ontrast, patients assigned to initial medical stabilization
ho were in NYHA functional class I or II at two weeks had
much higher rate of deterioration. The death rate in shock
atients with low two-week functional status assigned to IMS
as similar to that of patients with stage D heart failure (11).
At two weeks after discharge, mental health status was
ignificantly higher in patients who were assigned to emer-
ency revascularization. The association is likely even stron-
er than estimated because incapacitated patients or those
iving in a nursing home did not complete the MILQ
uestionnaire. These excluded patients tended to more
ften be from the IMS group, presumably had lower mental
ealth status, and had a high post-discharge death rate of 36%.
he relationship between life satisfaction and risk of death is
onsistent with previous findings showing the independent
rognostic value of life satisfaction over traditional markers
ncluding left ventricular ejection fraction (12,13).
A strategy of early revascularization, higher systolic blood
ressure on support measures after shock onset, and the
bsence of chest pain at presentation were found to be
ndependent predictors of a good one-year outcome. The
ystolic blood pressure at shock onset reflects residual left
entricular systolic reserve and the compensatory vasocon-
trictive response of the systemic vasculature. Inflammatory
ediators and inducible nitric oxide synthase expression
ffect the latter, and these mediators may also play a role in
he outcome (14). Early revascularization in the acute
etting, despite its acute risks, is a superior strategy with
espect to one-year survival and functional status. These
ndings should help dispel the bias against early revascu-
arization in critically ill patients with moderate to severe left
entricular dysfunction. Patients who remain severely limited
n their functional capacity after revascularization should be
onitored closely with early referral to additional therapies
uch as wearable left ventricular assist devices, to cardiac
esynchronization therapy, and to participation in protocols
valuating newer therapies (gene and cell therapies).
This analysis of functional class in the SHOCK trial has
everal limitations. Six-month and one-year interviewsithin the specified time window were not available for
pproximately 25% of patients. However, age is a potent
redictor of physical functioning, and in this study the age
istribution of patients with and without an interview was
imilar. In addition, 16% of the two-week interviews were
btained by proxy when the patient was incapacitated or
nwilling to be interviewed, and therefore it was not
ppropriate to collect quality-of-life data using the MILQ
uestionnaire. Therefore, the quality-of-life scores reported
ere may be biased upward.
At one year, 83% of patients discharged alive after an
nitial hospitalization for cardiogenic shock were in NYHA
unctional class I or II. In particular, patients who under-
ent early revascularization had better mental health im-
ediately after discharge and were protected against dete-
ioration in their functional status over time. Moreover,
urvivors of early revascularization after shock can have
ecovery of physical function similar to that of patients with
lective revascularization. The intense use of resources in
he salvage of critically ill patients is justified.
cknowledgments
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